Patient Monitoring Devices Market 2030

Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% through 2019-2030.

Product Overview Patient monitoring devices are a technology used to collect and electronically transmit medical and health-related data from individuals at one location to a healthcare provider at another location. Patient monitoring equipment continuously tracks patient’s vital health signs, such as respiratory rate, heart rate, and rhythm, blood pressure, a saturation of blood oxygen, and many other parameters. These devices assist in examining the health condition of a patient and provide healthcare professionals with timely warnings about the delivery of medical services to the patient. Continuous patient monitoring has been found to have enabled early detection of patient deterioration and early treatment. Besides, wearable patient monitoring systems have provided patients with wireless technology with freedom and comfort. Market Highlights Patient Monitoring Devices Market is expected to project a notable CAGR of 6.2% in 2030. Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% throughout the forecast period, i.e., 2019-30. A key trend in inpatient care is the integration of monitoring technologies into smartphones and wireless devices, leading to the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, outpatient wireless EEG recorders, and outpatient event monitors, which are key factors that support market growth. The market has been accelerated by the change in lifestyle patterns and the increasing cases of chronic diseases among the global population. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Patient Monitoring Devices Market: Segments Cardiac Monitoring Devices Segment to grow with the highest CAGR during 2019-30 Patient Monitoring Devices Market is segmented by type as hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weight monitoring, and temperature monitoring devices. The cardiac monitoring devices segment is estimated to lead the market with a share of over 26.0% of in Patience monitoring device market in 2018 and this trend is expected to continue during the forecast period. This is attributed to an increase in the prevalence of different cardiovascular diseases throughout the world each year, such as congestive heart failure and stroke. The segment is rapidly gaining popularity among patients with chronic diseases such as diabetes, hypertension, and chronic respiratory diseases because remote patient monitoring devices can be used remotely to monitor critical parameters of patients. It is therefore expected to be the fastest-growing segment registering a CAGR of 6.7% during the forecast period. The hospital Segment to grow with the highest CAGR during 2019-30 Patient Monitoring Devices Market is segmented by End-user into hospitals, ambulatory surgery centers, home care settings, and others. The Ambulatory surgical centers are emerged as the leading end-user segment in 2018 and accounted for over XX.X of the market share. During the forthcoming years, the ambulatory surgical centers' segment is estimated to see around 6 percent growth. In developed economies, a large number of populations are inclined toward ASCs, as they are equipped with advanced patient monitoring devices and well-developed infrastructure. In ASCs, the conventional type of patient monitoring device is particularly preferred because it is cost-effective. Various advantages, such as the reduced risk of hospital-acquired infection, shorter hospital stay, and quality treatment, increase patient preference for ASCs, fostering the size of the market. The presence of advanced ICUs and emergency wards in hospitals and the increasing number of surgical procedures can primarily be attributed to significant market growth and a large share of the hospital segment.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Patient Monitoring Devices Market: Market Dynamics Drivers Rising Burden of Chronic Diseases Chronic heart disease, diabetes, and chronic respiratory diseases are the world's leading causes of mortality and morbidity. 75% of healthcare costs are accounted for by chronic care management. The rise in the prevalence of chronic circumstances places a huge financial burden on caregivers. It thus decreases readmissions and prevents hospitalizations that are avoidable. Besides, these technologies reduce the number of unnecessary trips to the doctor's office and reduce the travel costs required to receive quality medical care. Therefore, it is expected that the increasing focus on a healthy lifestyle, the increasing trend of self-monitoring and preventive medicine, and the growing concern for constant monitoring of patient health parameters will drive the growth of the overall market. Growing Preference for Home and Remote Monitoring Due to the increasing prevalence of cardiovascular diseases worldwide, the cardiac monitoring devices segment valuation in 2019 was over USD 2.4 billion. Different surgical treatments are performed on a large population base suffering from cardiovascular diseases and require accurate monitoring of vital parameters affecting the market growth. Besides, manufacturers such as Medtronic have introduced technologically advanced products to obtain accurate information that further stimulates the expansion of the market for better patient care. A few applications for wearable patient monitoring devices, biosensors, and smart implants are continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things technology is equipped with new-generation wearable devices that increase remote monitoring.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Restrain Risk associated with invasive monitoring devices Several risks are associated with the use of invasive monitoring systems, such as discomfort associated with the insertion of monitoring tools, such as pulmonary artery catheters (PAC). Some other major risks are air embolism, sepsis, bleeding/hematoma formation, cardiac arrhythmias, decreased distal limb circulation, hemorrhage, damage to the nerves (during insertion), thrombosis, air embolism, and pulmonary capillary necrosis. The mortality rate during invasive procedures is increased by these factors. Consequently, the risks mentioned above limit the use of invasive monitoring devices. Patient Monitoring Devices Market: Key Players Abbott Laboratories Company Overview Business Strategy Key Product Offerings Financial Performance Key Performance Indicators Risk Analysis Recent Development Regional Presence SWOT Analysis Aerotel Medical Systems AMD Global Telemedicine Baxter International Inc. Boston Scientific Corporation GE Healthcare Masimo Corporation Medtronic PLC Omron Corporation Patient Monitoring Devices Market: Regions Patient Monitoring Devices Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA. Patient Monitoring Devices Market in North America led the market in 2018. The key factors supporting market growth in North America are increasing R&D to develop novel sensor-based patient monitoring systems, increasing infectious disease prevalence, safety concerns, and technological advances in patient monitoring device products. Besides, most of the world's leading companies are headquartered in the region or have a strong presence in that market, another key factor that is attributed to the market's significant growth. Europe, particularly Western European countries, is expected to remain the second most profitable region over the forecast period due to a higher mortality rate and rising demand for low-cost treatment. High-impact drivers for regional growth are increasing demand for in-house monitoring, supportive central data management systems, and increasing the accuracy and efficiency of remote patient monitoring systems. Competitive Landscape: The Patient Monitoring Devices market, which is highly competitive, consists of several major players such as Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany) hold a substantial market share in the Patient Monitoring Devices market. Other players analyzed in this report are Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (US), among others. Key players are adopting inorganic growth strategies such as product launches in the global nutritional supplement market. For instance, In December 2019, Masimo Corporation received FDA approval for the Neonatal RD SET Pulse Oximetry Sensors. Clinical studies have shown that the use of these oximeters reduces severe retinopathy in neonates. Patient Monitoring Devices Market is further segmented by region into: North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA Patient Monitoring Devices Market report also contains analysis on: Patient Monitoring Devices Market Segments: By Product: Hemodynamic Monitoring Devices Blood Glucose Cholesterol Blood Gas & Electrolyte Analyzers/Monitors Blood Pressure Neuromonitoring Devices Electroencephalograph (EEG) Devices Transcranial Dopplers (TCD) Magnetoencephalography (MEG) Devices Intracranial Pressure Monitors (ICP) Cerebral Oximeters Cardiac Monitoring Devices Electrocardiogram (ECG) Devices Holter Monitor Event Monitors Others Fetal & Neonatal Monitoring Devices Ultrasound Electronic Fetal Monitoring Devices Fetal Doppler Monitoring Devices Other Fetal & Neonatal Monitoring Devices Respiratory Monitoring Devices Capnographs Spirometers Sleep Apnea Monitor Pulse Oximeters Multiparameter Monitoring Devices High Acuity Mid Acuity Low Acuity Remote Patient Monitoring Devices Weight Monitoring Devices Temperature Monitoring Devices By End User: Hospitals Ambulatory Surgery Centers Home Care Settings Other Patient Monitoring Devices Market Dynamics Patient Monitoring Devices Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies Involved in the Market Value Chain of the Market Market Drivers and Restraints

Table of Contents

  • Contents
  • 1. Executive Summary
  • 2. Patient Monitoring Devices Market
  • 2.1. Product Overview
  • 2.2. Market Definition
  • 2.3. Segmentation
  • 2.4. Assumptions and Acronyms
  • 3. Research Methodology
  • 3.1. Research Objectives
  • 3.2. Primary Research
  • 3.3. Secondary Research
  • 3.4. Forecast Model
  • 3.5. Market Size Estimation
  • 4. Average Pricing Analysis
  • 5. Macro-Economic Indicators
  • 6. Market Dynamics
  • 6.1. Growth Drivers
  • 6.2. Restraints
  • 6.3. Opportunity
  • 6.4. Trends
  • 7. Correlation & Regression Analysis
  • 7.1. Correlation Matrix
  • 7.2. Regression Matrix
  • 8. Recent Development, Policies & Regulatory Landscape
  • 9. Risk Analysis
  • 9.1. Demand Risk Analysis
  • 9.2. Supply Risk Analysis
  • 10. Patient Monitoring Devices Analysis
  • 10.1. Porters Five Forces
  • 10.1.1. Threat of New Entrants
  • 10.1.2. Bargaining Power of Suppliers
  • 10.1.3. Threat of Substitutes
  • 10.1.4. Rivalry
  • 10.2. PEST Analysis
  • 10.2.1. Political
  • 10.2.2. Economic
  • 10.2.3. Social
  • 10.2.4. Technological
  • 11. Patient Monitoring Devices Market
  • 11.1. Market Size & forecast, 2019A-2030F
  • 11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12. Remote Patient Monitoring (RPM): Market Segmentation
  • 12.1. By Regions
  • 12.1.1. North America: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.1.2. Europe: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.1.3. Asia-Pacific: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.1.4. MEA: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.1.5. Latin America: By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2. By Type: Market Share (2020-2030F)
  • 12.2.1. Hemodynamic Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.2. Neuromonitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.3. Cardiac Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.4. Fetal & Neonatal Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.5. Respiratory Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.6. Multiparameter Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.7. Remote Patient Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.8. Weight Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.2.9. Temperature Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.3. By End User: Market Share (2020-2030F)
  • 12.3.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.3.2. Ambulatory Surgery Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.3.3. Home Care Settings, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 12.3.4. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  • 13. Company Profile
  • 1. Abbott Laboratories
  • 1. Company Overview
  • 2. Company Total Revenue (Financials)
  • 3. Market Potential
  • 4. Global Presence
  • 5. Key Performance Indicators
  • 6. SWOT Analysis
  • 7. Product Launch
  • 2. Aerotel Medical Systems
  • 3. AMD Global Telemedicine
  • 4. Baxter International Inc.
  • 5. Boston Scientific Corporation
  • 6. GE Healthcare
  • 7. Masimo Corporation
  • 8. Medtronic PLC
  • 9. Omron Corporation
  • Consultant Recommendation
  • **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Logo

Patient Monitoring Devices Market 2030

Contact usWe are friendly and approachable, give us a call.